InVisory Announces Salesforce Thought Leader Ben McCarthy 22-02-2023, 23:05

SHARED INTEREST PRESENTS A VIRTUAL CONVERSATION ON SOCIAL 8-03-2023, 22:27

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00